Infection of hemodialysis arteriovenous grafts

Journal of Vascular Access

Volumn 11, Issue 2, 2010, Pages 155-158

  Akoh, Jacob A ^a   Patel, Neil ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Bypass graft; Infection; Total graft excision

Indexed keywords

ANTIBIOTIC AGENT; POLITEF;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD VESSEL PROSTHESIS; CLOSTRIDIUM DIFFICILE INFECTION; COLIFORM BACTERIUM; FEMALE; GRAFT INFECTION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY;

EID: 78649404014     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.1177/112972981001100213     Document Type: Article

References (27)

1. Fong IW, Capella JM, Simbul M, Angel J. Infection of arteriovenous fistulas created for chronic haemodialysis. Scand J Infect Dis 1993; 25: 215-20. (Pubitemid 23149010)
2. Churchill DN, Taylor DW, Cook RJ et al. Canadian hemodialysis morbidity study. Am J Kidney Dis 1992; 19: 214-34.
3. Ryan SV, Calligaro KD, Scharff J, Dougherty MJ. Management of infected prosthetic dialysis arteriovenous grafts. J Vasc Surg 2004; 39: 73-8. (Pubitemid 38056155)
4. Englesbe MJ, Al-Holou WN, Moyer AT, et al. Single centre review of femoral arteriovenous grafts for haemodialysis. World J Surg 2006; 30: 171-5.
5. Schutte WP, Helmer SD, Salazar L, Smith JL. Surgical treatment of infected prosthetic dialysis arteriovenous grafts: total versus partial graft excision. Am J Surg 2007; 193: 385-8. (Pubitemid 46274595)
6. Cull JD, Cull DL, Taylor SM, et al. Prosthetic thigh arteriovenous access: outcome with SVS/AAVS reporting standards. J Vasc Surg 2004; 39: 381-6.
7. Lin PH, Brinkman WT, Terramani TT, Lumsden AB. Management of infected hemodialysis access grafts using cryopreserved human vein allografts. Am J Surg 2002; 184: 31-6.
8. Peng CW, Tan SG. Polyurethane grafts: a viable alternative for dialysis arteriovenous access? Asian Cardiovasc Thorac Ann 2003; 11: 314-8.
9. Mailloux LU, Bellucci AG, Wilkes BM, et al. Mortality in dialysis patients (analysis of the course of death). Am J Kidney Dis 1991; 18: 326-35.
10. Davidson I, Gallieni M, Saxena R, Dolmatch B. A patient centered decision making dialysis access algorythm. J Vasc Access 2007; 8: 59-68. (Pubitemid 47062113)
11. Schild AF, Simon S, Prieto J, Raines J. Single-center review of infections associated with 1574 consecutive vascular access procedures. Vasc Endovasc Surg 2003; 37: 27-31. (Pubitemid 36177205)
12. Taylor SM, Eaves GL, Weatherford DA, McAlhany JC Jr, Russell HE, Langan EM 3rd. Results and complications of arteriovenous access dialysis grafts in the lower extremity: a five year review Am Surg 1996; 62: 188-91.
13. Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int 2001; 60: 1-13.
14. Minga TE, Flanagan KH, Allon M. Clinical consequences of infected arteriovenous grafts in hemodialysis patients. Am J Kidney Dis 2001; 38: 975-8. (Pubitemid 33022174)
15. Salimi J. Patency rate and complications of vascular access grafts for haemodialysis in lower extremities. Saudi J Kidney Dis Transpl 2008; 19: 929-32.
16. Khadra MH, Dwyer AJ, Thompson JF. Advantages of polytetrafluoroethylene arteriovenous loops in the thigh for hemodialysis access. Am J Surg 1997; 173: 280-3.
17. Tashjian DB, Lipkowitz GS, Madden RL, et al. Safety and efficacy of femoral-based haemodialysis access grafts. J Vasc Surg 2002; 35: 691-3.
18. Slater ND, Raftery AT. An evaluation of expanded polytetrafluoroethylene (PTFE) loop grafts in the thigh as vascular access for haemodialysis in patients with access problems. Ann R Coll Surg Engl 1988; 70: 243-5.
19. Yasim A, Gul M, Atahan E, Ciragil P, Aral M, Ergun Y. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat. Eur J Vasc Endovasc Surg 2006; 31: 274-9. (Pubitemid 43263510)
20. Zibari GB, Gadallah MF, Landreneau M, et al. Preoperative vancomycin prophylaxis decreases incidence of postoperative hemodialysis vascular access infections. Am J Kidney Dis 1997; 30: 343-8. (Pubitemid 27391501)
21. Fivush BA, Bock GH, Guzzetta PC, Salcedo JR, Ruley EJ. Vancomycin prevents polytetrafluoroethylene graft infections in pediatric patients receiving chronic hemodialysis. Am J Kidney Dis 1985; 5: 120-3.
22. Matsuura JH, Rosenthal D, Wellons ED, Castronovo CS, Fronk D. Haemodialysis graft infections treated with cryopreserved femoral vein. Cardiovasc Surg 2002; 10: 561-5. (Pubitemid 35365868)
23. Darby CR, Roy D, Deardon D, Cornall A. Depopulated bovine ureteric xenograft for complex haemodialysis vascular access. Eur J Vasc Endovasc Surg 2006; 32: 181-6. (Pubitemid 43078947)
24. Chemla ES, Morsy M. Randomized clinical trial comparing decellularized bovine ureter with expanded polytetrafluoroethylene for vascular access. Br J Surg 2009; 96: 34-9.
25. Raju S. PTFE grafts for hemodialysis access: techniques for insertion and management of complications. Ann Surg 1987; 206: 666-73. (Pubitemid 18012149)
26. Taylor B, Sigley RD, May KJ. Fate of infected and eroded hemodialysis grafts and autogenous fistulas. Am J Surg 1993; 165: 632-6. (Pubitemid 23278682)
27. Lentino JR, Baddour LM, Wray M, Wong ES, Yu VL. Staphylococcus aureus and other bacteremias in hemodialysis patients: antibiotic therapy and surgical removal of access site. Infection 2000; 28: 355-60.